Biotin deficiency: risk groups and replenishment
What is known about biotin deficiency risk and why correcting deficiency cannot be equated with a cosmetic effect in everyone.
Key points
- If biotin deficiency is confirmed, replenishment can help resolve related symptoms. If insufficiency is suspected, finding the cause matters because similar signs occur in other conditions. [1] [2] [3] [4] See the evidence 1
- Reports of correcting deficiency do not show how hair, skin or nails will change in people without deficiency. A large dose alone does not mean a cosmetic effect. [1] [2] [3] [4] [5] [6] See the evidence 1 2
- Risk of insufficiency is higher with biotinidase deficiency, chronic alcohol consumption and prolonged consumption of raw egg whites. Belonging to a risk group alone is not a diagnosis. [1] [2] [3] [4] See the evidence 1
Practical guide
Check the conclusions and whether they apply to your situation.
Biotin deficiency is rare, but some conditions increase risk. Its signs can also have other causes.
Key points
Why these conclusions
Signs and risk factors
Biotin deficiency is rare; its signs can occur in other conditions. When deficiency is confirmed, replenishment can help resolve related symptoms. [1] [2] [3] [4]
Higher risk of insufficiency is associated with biotinidase deficiency, chronic alcohol consumption and prolonged consumption of raw egg whites. Inherited biotinidase deficiency requires specialised care. [1] [2] [3] [4]
Cases of correcting deficiency do not show what effect there would be on hair, skin or nails in people without deficiency. A high dose alone does not determine a cosmetic effect. [1] [2] [3] [4] [5] [6]
Information from the source
The US adequate intake (AI) reference includes biotin from food and supplements together. It is 30 mcg daily for adults and during pregnancy, and 35 mcg daily during breastfeeding. For children aged 1–3 it is 8 mcg, 4–8: 12 mcg, 9–13: 20 mcg and 14–18: 25 mcg daily. This is a general reference; it does not establish the dose of a particular supplement or a safe upper limit. Deficiency is rare. Its signs can occur in other conditions. 1 mg equals 1,000 mcg; 5 mg equals 5,000 mcg. A high dose alone says nothing about benefits for hair, skin or nails. Evidence is insufficient to set a tolerable upper intake level (UL). Biotin can interfere with test results even when a person notices no side effects. If deficiency is confirmed, replenishment can help resolve related symptoms. In inherited biotinidase deficiency, involving an enzyme that helps the body use biotin, specialised care is needed. The described cases do not show how hair, skin or nails will change in people without deficiency. Risk of insufficiency is higher with biotinidase deficiency, chronic alcohol consumption and prolonged consumption of raw egg whites. Belonging to a risk group alone is not a diagnosis. In a vision study in multiple sclerosis, relapses were reported by 9 of 65 participants taking 300 mg biotin daily and 1 of 28 on placebo. A link to biotin was not established. One participant developed a retinal artery blockage and withdrew. Researchers considered a link to use possible. They also noted that biotin interfered with thyroid-function tests. [1] [2] [3] [4]
Information from the source
| Name | Description | Sources |
|---|---|---|
| Biotin in supplements | Amounts are given in micrograms or milligrams: 1 mg = 1,000 mcg; 5 mg = 5,000 mcg. A high dose alone does not determine a cosmetic effect. | [4] |
| Research doses | In a vision trial in multiple sclerosis, MD1003 was used at 300 mg/day. A small metabolic trial used 15 mg/day; this value incorporates the published 2007 correction. | [1] [6] [5] |
Sources
- MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study. https://pubmed.ncbi.nlm.nih.gov/29808469/
- Biotinidase Deficiency. https://www.ncbi.nlm.nih.gov/books/NBK1322/
- Biotin Interference with Troponin Lab Tests — Assays Subject to Biotin Interference. https://www.fda.gov/medical-devices/in-vitro-diagnostics/biotin-interference-troponin-lab-tests-assays-subject-biotin-interference
- Biotin — Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Biotin-HealthProfessional/
- Erratum: Effects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects. https://ajcn.nutrition.org/article/S0002-9165%2823%2927949-6/fulltext
- Effects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl-CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and nondiabetic subjects. https://pubmed.ncbi.nlm.nih.gov/14749229/
Methodology: Subpages evidence-led supplement pipeline v1